Search Results

dsm-firmenich and Zerion Pharma form a partnership to develop improved cannabinoids

Zerion Pharma A/S (“ZERION”) today announces an exclusive partnership with dsm-firmenich to take advantage of ZERION’s expertise and its Dispersome®

February 15, 2024

·

2 min read

Firmenich Enters Strategic Partnership with Essential Labs, LLC, a Leading B2B E-Commerce Supplier of Fragrance Solutions

Firmenich, the world’s largest privately-owned fragrance and taste company, has entered into a strategic partnership with Essential Labs, LLC, a leading B2B supplier of fragrance solutions supporting entrepreneurial, independent businesses in the premium home segment.

May 18, 2021

·

2 min read

Press Releases

EMN Raises Series A Funding to Revolutionize Nutrition for Surgery

January 14, 2025

·

4 min read

Deals

FIRMENICH TO ACQUIRE SENOMYX, PIONEER IN TASTE INNOVATION

Firmenich and Senomyx, Inc. today announced that they have entered into a definitive merger agreement under which Firmenich will acquire all of the outstanding common stock of Senomyx for $1.50 per share in cash.

September 17, 2018

·

8 min read

Deals

FIRMENICH COMMENCES TENDER OFFER TO ACQUIRE SENOMYX

Firmenich Incorporated announced today that its wholly-owned U.S. subsidiary, Sentry Merger Sub, Inc., commenced the previously announced tender offer to acquire all of the outstanding common stock of Senomyx, Inc.

October 4, 2018

·

6 min read

Business

Senomyx Expands Cool Program Collaboration With Firmenich

Under terms of the amended agreement, Firmenich will be granted an exclusive license to Coolmyx CL19 and related cooling ingredients in all product categories.

November 14, 2017

·

5 min read

Press Releases

Skye Bioscience Names Independent Director Paul Grayson as Chairman of the Board

October 29, 2024

·

4 min read

Biotech Bay

Hologram Sciences to Showcase Innovation in Nutrition Tech and Generative AI at the 42nd Annual J.P. Morgan Healthcare Conference

Hologram Sciences, a leader in the field of generative AI and nutrition technology, is set to attend the 42nd Annual J.P. Morgan Healthcare Conference from January 8-11, 2024, in San Francisco, California.

December 21, 2023

·

3 min read

Pharm Country

Advent Therapeutics Awarded $3 Million NIH Grant for Novel Neonatal Lung Therapy

Advent Therapeutics, Inc. has been awarded a $3 million National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Phase IIB grant.

July 18, 2023

·

8 min read

Business

Radionetics Oncology Raises $52.5 Million Series A to Advance First-in-Class Radiopharmaceutical Pipeline and Announces the Appointment of Industry Leader, Paul Grayson, as CEO

Radionetics Oncology, Inc. announces the completion of a $52.5 million Series A financing.

January 3, 2024

·

3 min read